Product Information
GS ANTI-DIARRHEAL 2 MG CAPLET is a generic product labeled by L. Perrigo Company, priced at $0.1299 per EA under NDC 00113022462. Its NADAC has been published 434 times since Jun 13, 2018.
FDA first approved this application on Jan 6, 2000.
Strength
2 mg/1
Manufacturer
L. Perrigo CompanyNDC
00113022462
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LOPERAMIDE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075232FDA Approved
1/6/2000
On Market Since
2/25/2003
Pharmacological Classes
Price Statistics
The NADAC for GS ANTI-DIARRHEAL 2 MG CAPLET has been published 434 times since Jun 13, 2018, and over the history we have for it it has risen 8.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1299 per EA |
|---|---|
| All-time high | $0.1995 (May 10, 2023) |
| All-time low | $0.1060 (Mar 20, 2019) |
| 52-week high | $0.1465 |
| 52-week low | $0.1233 |
| Median price | $0.1319 |
| Average price | $0.1346 |
| Largest weekly change | +26.8% (Sep 20, 2023) |
| Weeks tracked | 434 |
| Tracking since | Jun 13, 2018 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 7% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
L. Perrigo Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Loperamide Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GS ANTI-DIARRHEAL 2 MG CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for GS ANTI-DIARRHEAL 2 MG CAPLET, manufactured by L. Perrigo Company, is $0.1299 per EA (NDC 00113022462), effective Sep 30, 2026.
How has the price of GS ANTI-DIARRHEAL 2 MG CAPLET changed over time?
Over the history we have for it, the NADAC for GS ANTI-DIARRHEAL 2 MG CAPLET has risen 8.9%. It has been tracked across 434 weekly CMS publications since Jun 13, 2018.
What are the highest and lowest recorded NADAC prices for GS ANTI-DIARRHEAL 2 MG CAPLET?
Since Jun 13, 2018, the NADAC for GS ANTI-DIARRHEAL 2 MG CAPLET has ranged from a low of $0.1060 (Mar 20, 2019) to a high of $0.1995 (May 10, 2023), with a median of $0.1319 per EA.
Are there cheaper alternatives to GS ANTI-DIARRHEAL 2 MG CAPLET?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QC ANTI-DIARRHEAL 2 MG CAPLET, is $0.1204 per EA — about 7% below GS ANTI-DIARRHEAL 2 MG CAPLET.
Who manufactures GS ANTI-DIARRHEAL 2 MG CAPLET?
GS ANTI-DIARRHEAL 2 MG CAPLET (NDC 00113022462) is labeled by L. Perrigo Company, and CMS classifies it as a generic product.